Adjuvant trastuzumab in HER2-positive breast cancer D Slamon, W Eiermann, N Robert, T Pienkowski, M Martin, M Press, ... New England journal of medicine 365 (14), 1273-1283, 2011 | 3177 | 2011 |
Adjuvant docetaxel for node-positive breast cancer M Martin, T Pienkowski, J Mackey, M Pawlicki, JP Guastalla, C Weaver, ... New England Journal of Medicine 352 (22), 2302-2313, 2005 | 1343 | 2005 |
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer S Chan, K Friedrichs, D Noel, T Pintér, S Van Belle, D Vorobiof, R Duarte, ... Journal of Clinical Oncology 17 (8), 2341-2341, 1999 | 823 | 1999 |
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase … JM Nabholtz, C Falkson, D Campos, J Szanto, M Martin, S Chan, ... Journal of Clinical Oncology 21 (6), 968-975, 2003 | 501 | 2003 |
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. R Bruno, D Hille, A Riva, N Vivier, WW ten Bokkel Huinnink, ... Journal of clinical oncology 16 (1), 187-196, 1998 | 489 | 1998 |
Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials MF Press, G Sauter, L Bernstein, IE Villalobos, M Mirlacher, JY Zhou, ... Clinical Cancer Research 11 (18), 6598-6607, 2005 | 426 | 2005 |
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer MD Pegram, T Pienkowski, DW Northfelt, W Eiermann, R Patel, ... Journal of the National Cancer Institute 96 (10), 759-769, 2004 | 364 | 2004 |
Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene … V Valero, J Forbes, MD Pegram, T Pienkowski, W Eiermann, ... Journal of clinical oncology 29 (2), 149-156, 2011 | 283 | 2011 |
Alteration of topoisomerase II–alpha gene in human breast cancer: Association with responsiveness to anthracycline-based chemotherapy MF Press, G Sauter, M Buyse, L Bernstein, R Guzman, A Santiago, ... Journal of Clinical Oncology 29 (7), 859, 2011 | 262 | 2011 |
Dynamic organization of mitochondria in human heart and in myocardial disease CL Hoppel, B Tandler, H Fujioka, A Riva The international journal of biochemistry & cell biology 41 (10), 1949-1956, 2009 | 199 | 2009 |
Structural differences in two biochemically defined populations of cardiac mitochondria A Riva, B Tandler, F Loffredo, E Vazquez, C Hoppel American Journal of Physiology-Heart and Circulatory Physiology 289 (2 …, 2005 | 197 | 2005 |
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2 … W Eiermann, T Pienkowski, J Crown, S Sadeghi, M Martin, A Chan, ... J Clin Oncol 29 (29), 3877-3884, 2011 | 186 | 2011 |
Morphology and functions of the human seminal vesicle G Aumüller, A Riva Andrologia 24 (4), 183-196, 1992 | 185 | 1992 |
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer JL Misset, V Dieras, G Gruia, H Bourgeois, E Cvitkovic, S Kalla, L Bozec, ... Annals of oncology 10 (5), 553-560, 1999 | 160 | 1999 |
Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer JM Nabholtz, JR Mackey, M Smylie, A Paterson, DR Noel, T Al-Tweigeri, ... Journal of clinical oncology 19 (2), 314-321, 2001 | 135 | 2001 |
A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC P Fumoleau, B Chevallier, P Kerbrat, Y Krakowski, JL Misset, ... Annals of oncology 7 (2), 165-171, 1996 | 116 | 1996 |
The evolution of anatomical illustration and wax modelling in Italy from the 16th to early 19th centuries A Riva, G Conti, P Solinas, F Loy Journal of anatomy 216 (2), 209-222, 2010 | 104 | 2010 |
Fine structure of acinar cells of human parotid gland A Riva, F Riva‐Testa The Anatomical Record 176 (2), 149-165, 1973 | 98 | 1973 |
A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC V Dieras, B Chevallier, P Kerbrat, I Krakowski, H Roche, JL Misset, ... British journal of cancer 74 (4), 650-656, 1996 | 97 | 1996 |
Environmental and serological evidence for the presence of toxocariasis in the urban area of Ancona, Italy A Giacometti, O Cirioni, M Fortuna, P Osimani, L Antonicelli, MS Del Prete, ... European journal of epidemiology 16, 1023-1026, 2000 | 92 | 2000 |